Lippincott ^® NursingCenter ^®

Departments

• Free

  3 QUESTIONS ON... Cancer Rates in Medieval Populations: With Piers Mitchell, MD, Director of the Ancient Parasites Laboratory at University of Cambridge

  Sarah DiGiulio

• Free

  A Model to Predict NSCLC Patient Outcomes to Immunotherapy
• Free

  Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Metastatic Melanoma
• Free

  Blood Pressure Drugs Could Improve Colorectal Cancer Survival
• Free

  Combination Therapy Provides Remission for Chronic Lymphocytic Leukemia

  Sarah LaCorte

• Free

  Conferences & Courses
• Free

  Entinostat Aids Response to Treatment With Immunotherapy
• Free

  From Active Surveillance to Active Treatment in Prostate Cancer
• Free

  Genomic Markers of Aggressive Childhood Leukemias Identified
• Free

  Heat-Controllable CAR T Cells Destroy Tumors & Prevent Relapse
• Free

  Immune Cells in Canine Brain Tumors Could Provide Therapeutic Targets
• Free

  Musings of a Cancer Doctor: On the Limits of Endurance

  George W. Sledge MD

• Free

  New Hope for NSCLC Patients With EGFR Exon 20 Insertion Mutations

  Dibash Kumar Das PhD

• Free

  Novel AI Blood Testing Technology Can ID Lung Cancers With High Accuracy
• Free

  Pembrolizumab Shows No Benefit in Advanced Urothelial Carcinoma

  Peter M. Goodwin

• Free

  PULSAR-Integrated Radiotherapy to Improve Tumor Control
• Free

  Topical HDAC Inhibitor Gel Treats Basal Cell Carcinoma

  Mark L. Fuerst

• Free

  UpToDate
• Buy

  A Biomarker That May Help Predict Benefits of Immunotherapy
• Buy

  Assessment of Survival Benefit in Early-Onset Colorectal Cancer

  Dibash Kumar Das PhD

• Buy

  CAR T-Cell Therapy Emerges as Option in Follicular Lymphoma

  Mary Ellen Schneider

• Buy

  FDA Updates Highlighting the Latest Cancer Treatments
• Buy

  Pertuzumab/Trastuzumab/Hyaluronidase-Zzxf (Phesgo™)

  Cassandra Perkey PharmD, BCOP

• Buy

  Protocol Alerts
• Buy

  Reviewing Time to Treatment for Breast Cancer Patients

  Debra A. Pratt MD, FACS

• Buy

  Shop Talk
• Buy

  Study Identifies Biomarker for Breast Cancer Response to Immunotherapy

  Amy Gallagher